BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA

被引：0
|
作者：
Londono, S. [1 ]
Gomez, N. [1 ]
机构：
[1] Sanofi, Bogota, Cun, Colombia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND19
引用
收藏
页码：S625 / S625
页数：1
相关论文
共 50 条
  • [21] BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S205 - S205
  • [22] Acute leukocytosis during alemtuzumab treatment in patients with active relapsing-remitting multiple sclerosis
    Iovino, Aniello
    Aruta, Francesco
    Carotenuto, Antonio
    Manganelli, Fiore
    Iodice, Rosa
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 98 - 100
  • [23] Alemtuzumab and Thyroid Autoimmunity in Relapsing-Remitting Multiple Sclerosis Patients in CAMMS223
    Brinar, Vesna
    [J]. NEUROLOGY, 2011, 76 (09) : A246 - A246
  • [24] Efficacy of alemtuzumab in relapsing-remitting multiple sclerosis is independent of baseline status
    Coles, A. J.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 55 - 55
  • [25] Alopecia totalis following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Zimmermann, J.
    Buhl, T.
    Mueller, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 382 - 382
  • [26] Immunosuppresion following alemtuzumab in relapsing-remitting multiple sclerosis patients previously treated With fingolimod
    Maria Cabrera-Maqueda, Jose
    Fuentes Rumi, Luna
    Valero Lopez, Gabriel
    Alba Isasi, Teresa
    Hernandez-Clares, Rocio
    Carreon Guarnizo, Ester
    Jimenez Veiga, Judith
    Iniesta-Martinez, Francisca
    Leon-Hernandez, Aida
    Zamarro Parra, Joaquin
    Morales Ortiz, Ana
    Meca Lallana, Jose
    [J]. NEUROLOGY, 2019, 92 (15)
  • [27] Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients
    Studer, Valeria
    Ferri, Anna
    Perugini, Jacopo
    Clerici, Valentina Torri
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    Schilke, Edoardo
    Brambilla, Laura
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 26
  • [28] Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis
    Ladwig, A.
    Suh, J.
    Schweitzer, F.
    Roeth, P.
    Remke, G.
    Warnke, C.
    Schroeter, M.
    Izquierdo-Alvarez, E.
    Bonmann, E.
    Fink, G. R.
    Pallasch, C.
    Lehmann, H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 259 - 259
  • [29] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [30] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
12345